Overview

Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec

Status:
Completed
Trial end date:
2020-03-18
Target enrollment:
Participant gender:
Summary
Multi-center, open-label, multiple dose safety, tolerability and efficacy study
Phase:
Phase 2
Details
Lead Sponsor:
Diasome Pharmaceuticals
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc
Insulin, Long-Acting